T1	Limited_variation	0 13	The rs8099917
T2	Pharmacodynamic_phenotype	64 110	response to the PEG -IFN / RBV treatment among
T3	Disease	120 148	chronic hepatitis C patients
R1	influences	Arg1:T1	Arg2:T2
R2	influences	Arg1:T1	Arg2:T3
R3	treats	Arg1:T2	Arg2:T3
R4	isAssociatedWith	Arg1:T3	Arg2:T1
R5	influences	Arg1:T3	Arg2:T2
